Emergence is a business incubator dedicated to assisting start-ups and growth stage bioscience companies in efficiently bringing their products and services to market. Emergence clients benefit from access to business, technical, scientific and regulatory support services customized to meet their individual needs. This includes one-on-one and team-based mentorship; third-party consulting services; market research; legal, IP, insurance, tax and financial expertise from a network of professional service provider partners; and support accessing international networks and public and private funding and investment opportunities. Emergence serves high-potential companies wherever they are located in Canada, while also providing a “soft landing” for innovative international bioscience ventures seeking to start-up or establish themselves in, or expand into, Canada.
39
Total Investments
14
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
About Emergence
Recent Investments (39)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Growth Equity Vc | •••••• | Sep 2025 | |
| Series B | •••••• | Feb 2025 | |
| Late Vc | •••••• | Oct 2022 | |
| Series D | •••••• | Jul 2022 | |
| Series C | •••••• | Apr 2022 | |
|
|
Late Vc | •••••• | Jan 2022 |
|
|
Series B | •••••• | Jun 2021 |
|
|
Series E | •••••• | Jun 2021 |
|
|
Series D | •••••• | Jun 2021 |
|
|
Series C | •••••• | Apr 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.